Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
See Latest ArticlesCompartmental intrathecal radioimmunotherapy: results for treatment for metastatic CNS neuroblastoma
Journal of Neuro-Oncology, 11/10/09
Kramer K et al. – The cRIT–salvage regimen for CNS metastases was well tolerated by young patients, despite their prior history of intensive cytotoxic therapies. It has the potential to increase survival with better than expected quality of life.
Related Articles
Microtubule-associated Protein-2 is a Sensitive Marker of Primary and Metastatic Neuroblastoma
American Journal of Surgical Pathology, 10/28/09
Relevance Score: 66%
Primary postoperative chemotherapy without radiotherapy for treatment of brain tumours other than ependymoma in children under 3 years: Results of the first UKCCSG/SIOP CNS 9204 trial
European Journal of Cancer, 10/13/09
Relevance Score: 63%
Gene expression profiling of primary and metastatic colon cancers identifies a reduced proliferative rate in metastatic tumors
Clinical and Experimental Metastasis, 11/05/09
Relevance Score: 46%
Prognostic factors in metastatic melanoma patients treated with biochemotherapy and maintenance immunotherapy
The Oncologist, 10/30/09
Relevance Score: 46%
Phase II multicenter trial of anthracycline rechallenge with pegylated liposomal doxorubicin plus cyclophosphamide for first-line therapy of metastatic breast cancer previously treated with adjuvant anthracyclines
Journal of Clinical Oncology, 10/30/09
Relevance Score: 45%
Today in Neurologic Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Phase II trial of erlotinib with temozolomide and radiation in patients with newly diagnosed glioblastoma multiforme
Journal of Neuro-Oncology, 12/17/09
Secretory meningiomas: A benign subgroup causing life-threatening complications
Neuro-Oncology, 12/17/09
Characterization of novel and complex genomic aberrations in glioblastoma using a 32K BAC array
Neuro-Oncology, 12/17/09
Today in Pharmacology/Therapy...keeping you current
Receive free subspecialty "5-minute updates" via email
Comparative proteomic profiling identified sorcin being associated with gemcitabine resistance in non-small cell lung cancer
Medical Oncology, 12/17/09
Anti-tumor activity and mechanisms of a novel vascular disrupting agent, (Z)-3,4?,5-trimethoxylstilbene-3?-O-phosphate disodium (M410)
Investigational New Drugs, 12/17/09
A prospective phase II study of cetuximab in combination with XELOX (capecitabine and oxaliplatin) in patients with metastatic and/or recurrent advanced gastric cancer
Investigational New Drugs, 12/17/09
Sponsor
Article Search
Sponsor
Sponsor